Biotech Investors & VC Firms in Canada
123 firms in this list, with a median first check of $500K. 4 of them lead rounds. Generated from verified public data and updated continuously.
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Series B$16.2M
9 people
CIBC
ChicagoPre-Seed–Late Stage$1.5M – $29.2M
5 people
AQC Capital
MontrealPre-Seed–Series A
8 people
Innovobot
WestmountPre-Seed–Series A$182.5K – $365K
5 people
Nimbus Synergies Inc.
VancouverPre-Seed–Series A$182.5K – $1.5M
5 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
Shoreline Venture Management
San FranciscoSeed–Series A$250K – $1M
5 people
Invest Nova Scotia
HalifaxPre-Seed–Series A$73K – $730K
4 people
Auriga Partners
ParisSeed–Series A$540K – $5.4M
3 people
CTI Life Sciences Fund L.P.
MontrealSeed–Late Stage
6 people
Esplanade Ventures
WestmountSeed–Series A
6 people
KAYA
PraguePre-Seed–Late Stage
6 people
New Brunswick Innovation Foundation
FrederictonPre-Seed–Series A$36.5K – $730K
3 people
Seido Capital
BrusselsPre-Seed–Series B$270K – $2.7M
3 people
Entrada Ventures
Santa BarbaraPre-Seed–Series B
5 people
Saltagen Ventures
Seed–Series A
5 people
WELL Ventures
VancouverSeed–Growth
5 people
Boreal Ventures
MontrealPre-Seed–Series A$2.2M
2 people
DRI Healthcare
Toronto$7.3M – $36.5M
2 people
WUTIF Capital
VancouverPre-Seed–Series A$18.3K – $182.5K
2 people
AbbVie
CambridgeSeed–Late Stage$300K – $3M
1 person
CentreStone Ventures
WinnipegSeed–Series A$182.5K – $1.8M
1 person
Dow Venture Capital
MidlandSeed–Series A$250K – $5M
1 person
Pallasite Ventures
VancouverSeed–Series A$100K – $1.5M
1 person
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.